Showing results (11-20 of 108) with videos related to
Sort By:
Pageof 11
Plos One|May 7, 2013
Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical propertiesMichael P Menden, Francesco Iorio, Mathew Garnett, et al.Bioinformatics (Oxford, England)|August 8, 2014
Drug/Cell-line Browser: interactive canvas visualization of cancer drug/cell-line viability assay datasetsQiaonan Duan, Zichen Wang, Nicolas F Fernandez, et al.Plos One|July 21, 2018
Potent and selective effect of the mir-10b inhibitor MN-anti-mir10b in human cancer cells of diverse primary disease originByunghee Yoo, Patricia Greninger, Giovanna T Stein, et al.International Journal of Cancer|July 31, 2019
Radioresistance of KRAS/TP53-mutated lung cancer can be overcome by radiation dose escalation or EGFR tyrosine kinase inhibition in vivoKristin Gurtner, Zofia Kryzmien, Lydia Koi, et al.Cancer Research|July 3, 2014
CDK4/6 and IGF1 receptor inhibitors synergize to suppress the growth of p16INK4A-deficient pancreatic cancersAndreas M Heilmann, Rushika M Perera, Veronika Ecker, et al.Cancer Discovery|January 8, 2015
Lysine demethylase KDM4A associates with translation machinery and regulates protein synthesisCapucine Van Rechem, Joshua C Black, Myriam Boukhali, et al.STAR Protocols|March 29, 2021
Alginate-based 3D cancer cell culture for therapeutic response modelingFarideh Davoudi, Samar Ghorbanpoor, Satoshi Yoda, et al.Cancer Research|May 19, 2011
STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesisRyan B Corcoran, Gianmarco Contino, Vikram Deshpande, et al.Breast Cancer Research and Treatment|January 5, 2019
A common Chk1-dependent phenotype of DNA double-strand break suppression in two distinct radioresistant cancer typesPatrick H Dinkelborg, Meng Wang, Liliana Gheorghiu, et al.Cancer Discovery|January 1, 2013
Mcl-1 and FBW7 control a dominant survival pathway underlying HDAC and Bcl-2 inhibitor synergy in squamous cell carcinomaLei He, Kristine Torres-Lockhart, Nicole Forster, et al.Pageof 11